Abiopharma

🔍 MAY SIMON (Executive)

Company: AGILENT TECHNOLOGIES, INC. (A)

Report Date: 2026-05-08

Detailed Transactions and Holdings:

• Sold 368 shares of Common Stock at $115.62 per share (Direct)
  Date: 2026-05-08 | Code: F | equity_swap_involved: 0 | shares_owned_after: 14,015.49 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The reporting person surrendered 368 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3.
• F2: Includes 3.457 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan in transactions exempt under Rule 16a-11.
• F3: Includes 172.7831 shares acquired in an Employee Stock Purchase Plan under Section 423 of the Internal Revenue Code of 1986, as amended, in a transaction exempt under Rule 16b-3.